Home » Stocks » Citius Pharmaceuticals

Citius Pharmaceuticals, Inc. (CTXR)

Stock Price: $1.02 USD 0.00 (0.00%)
Updated Oct 27, 2020 1:42 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 47.24M
Revenue (ttm) n/a
Net Income (ttm) -17.08M
Shares Out 46.32M
EPS (ttm) -0.54
PE Ratio n/a
Forward PE 2.82
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $1.02
Previous Close $1.02
Change ($) 0.00
Change (%) 0.00%
Day's Open 1.02
Day's Range 1.01 - 1.03
Day's Volume 184,811
52-Week Range 0.40 - 1.97

More Stats

Market Cap 47.24M
Enterprise Value 40.06M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.32M
Float 34.74M
EPS (basic) -0.55
EPS (diluted) -0.54
FCF / Share -0.40
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 809,120
Short Ratio 0.89
Short % of Float 2.33%
Beta 1.10
PE Ratio n/a
Forward PE 2.82
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.12
Revenue n/a
Operating Income -17.23M
Net Income -17.08M
Free Cash Flow -16.48M
Net Cash 7.18M
Net Cash / Share 0.16
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -33.68%
ROE -67.97%
ROIC -97.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$5.50*
(439.22% upside)
Low
4.00
Current: $1.02
High
7.00
Target: 5.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520132012
Revenue-------
Operating Income-15.60-13.79-9.99-7.45-3.23-1.18-1.02
Net Income-15.56-12.54-10.38-8.30-2.90-1.29-1.05
Shares Outstanding20.1610.735.483.622.121.181.13
Earnings Per Share-0.77-1.17-1.89-2.29-1.37-1.05-0.90
Operating Cash Flow-12.44-11.32-7.97-5.90-2.39-1.10-0.92
Capital Expenditures-------
Free Cash Flow-12.44-11.32-7.97-5.90-2.39-1.10-0.92
Cash & Equivalents7.959.193.210.300.680.05-
Total Debt0.170.170.170.67-2.64-
Net Cash / Debt7.789.013.03-0.380.68-2.58-
Assets36.7531.0524.4221.950.740.11-
Liabilities9.593.182.475.181.383.01-
Book Value27.1527.8721.9516.77-0.64-2.90-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Citius Pharmaceuticals, Inc.
Country United States
Employees 9
CEO Myron Z. Holubiak

Stock Information

Ticker Symbol CTXR
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CTXR

Description

Citius Pharmaceuticals, a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.